Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors.

MLA

Suzuki, Yuta, et al. “Kidney Outcomes in Patients with Diabetes Mellitus Did Not Differ between Individual Sodium-Glucose Cotransporter-2 Inhibitors.” Kidney International, vol. 102, no. 5, Nov. 2022, pp. 1147–53. EBSCOhost, https://doi.org/10.1016/j.kint.2022.05.031.

APA

Suzuki, Y., Kaneko, H., Okada, A., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., Node, K., Nangaku, M., Yasunaga, H., & Komuro, I. (2022). Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors. Kidney International, 102(5), 1147–1153. https://doi.org/10.1016/j.kint.2022.05.031

Chicago

Suzuki, Yuta, Hidehiro Kaneko, Akira Okada, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, et al. 2022. “Kidney Outcomes in Patients with Diabetes Mellitus Did Not Differ between Individual Sodium-Glucose Cotransporter-2 Inhibitors.” Kidney International 102 (5): 1147–53. doi:10.1016/j.kint.2022.05.031.